These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 26260621)
1. The diagnostic value of tumor markers in bronchoalveolar lavage fluid for the peripheral pulmonary carcinoma. Zhang S; Zhao YF; Zhang MZ; Wu XL Clin Respir J; 2017 Jul; 11(4):481-488. PubMed ID: 26260621 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of bronchoalveolar lavage fluid and serum tumor markers for lung cancer. Wang H; Zhang X; Liu X; Liu K; Li Y; Xu H J Cancer Res Ther; 2016; 12(1):355-8. PubMed ID: 27072263 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of diagnostic value of four tumor markers in bronchoalveolar lavage fluid of peripheral lung cancer. Li J; Chen P; Mao CM; Tang XP; Zhu LR Asia Pac J Clin Oncol; 2014 Jun; 10(2):141-8. PubMed ID: 23551358 [TBL] [Abstract][Full Text] [Related]
4. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer. Jiang ZF; Wang M; Xu JL Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745 [TBL] [Abstract][Full Text] [Related]
5. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer. Wang B; He YJ; Tian YX; Yang RN; Zhu YR; Qiu H Asian Pac J Cancer Prev; 2014; 15(22):9611-4. PubMed ID: 25520076 [TBL] [Abstract][Full Text] [Related]
6. Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancer. Bai Y; Shen W; Zhu M; Zhang L; Wei Y; Tang H; Zhao J J Cell Biochem; 2019 Jan; 120(1):105-114. PubMed ID: 30216488 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of VEGF-C and tumor markers in bronchoalveolar lavage fluid for lung cancer diagnosis. Cao C; Chen ZB; Sun SF; Yu YM; Ding QL; Deng ZC Sci Rep; 2013 Dec; 3():3473. PubMed ID: 24326979 [TBL] [Abstract][Full Text] [Related]
8. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients. Zhang L; Liu D; Li L; Pu D; Zhou P; Jing Y; Yu H; Wang Y; Zhu Y; He Y; Li Y; Zhao S; Qiu Z; Li W BMC Cancer; 2017 Feb; 17(1):96. PubMed ID: 28152979 [TBL] [Abstract][Full Text] [Related]
9. Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China. Song WA; Liu X; Tian XD; Wang W; Liang CY; Zhang T; Guo JT; Peng YH; Zhou NK Chin Med J (Engl); 2011 Oct; 124(20):3244-8. PubMed ID: 22088515 [TBL] [Abstract][Full Text] [Related]
10. [Clinical Significance of Tumor Marker Detection in Patients with Advanced Squamous Cell Carcimoma of the Lung]. Liang P; Li J Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):641-647. PubMed ID: 27760591 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: a single center analysis. Chu XY; Hou XB; Song WA; Xue ZQ; Wang B; Zhang LB Cancer Biol Ther; 2011 Jun; 11(12):995-1000. PubMed ID: 21483235 [TBL] [Abstract][Full Text] [Related]
12. Prediction of Pleural Invasion in Challenging Non-Small-Cell Lung Cancer Patients Using Serum and Imaging Markers. Zhu K; Chen L; He C; Lang Y; Kong X; Qu C; Xu S Dis Markers; 2020; 2020():6430459. PubMed ID: 32089756 [TBL] [Abstract][Full Text] [Related]
13. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients. Dal Bello MG; Filiberti RA; Alama A; Orengo AM; Mussap M; Coco S; Vanni I; Boccardo S; Rijavec E; Genova C; Biello F; Barletta G; Rossi G; Tagliamento M; Maggioni C; Grossi F J Transl Med; 2019 Mar; 17(1):74. PubMed ID: 30849967 [TBL] [Abstract][Full Text] [Related]
14. Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. Wang WJ; Tao Z; Gu W; Sun LH Asian Pac J Cancer Prev; 2013; 14(7):4369-71. PubMed ID: 23992005 [TBL] [Abstract][Full Text] [Related]
15. Retrospective Study to Determine Diagnostic Utility of 6 Commonly Used Lung Cancer Biomarkers Among Han and Uygur Population in Xinjiang Uygur Autonomous Region of People's Republic of China. Yang-Chun F; Min F; Di Z; Yan-Chun H Medicine (Baltimore); 2016 May; 95(18):e3568. PubMed ID: 27149479 [TBL] [Abstract][Full Text] [Related]
16. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China. Ma L; Xie XW; Wang HY; Ma LY; Wen ZG Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610 [TBL] [Abstract][Full Text] [Related]
17. Elevated tumor markers in patients with pulmonary alveolar proteinosis. Fang SC; Lu KH; Wang CY; Zhang HT; Zhang YM Clin Chem Lab Med; 2013 Jul; 51(7):1493-8. PubMed ID: 23314555 [TBL] [Abstract][Full Text] [Related]
18. Determination of the best prognostic value of serum tumor markers in patients with suspected lung cancer in an Iranian population. Sigari N; Mohsenpour B; Nikkhoo B; Ghaderi B; Afkhamzadeh A; Azadi NA; Fathi F; Abdi M Clin Lab; 2014; 60(1):23-7. PubMed ID: 24600971 [TBL] [Abstract][Full Text] [Related]
19. Tumor markers and lung cancer: correlation between serum and bronchial secretion levels of CEA, TPA, CanAg CA-50, NSE and ferritin. Macchia V; Mariano A; Cavalcanti M; Coppa A; Cecere C; Fraioli G; Elia S; Ferrante G Int J Biol Markers; 1987; 2(3):151-6. PubMed ID: 2836526 [TBL] [Abstract][Full Text] [Related]
20. The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer. Wang P; Piao Y; Zhang X; Li W; Hao X Cancer Biomark; 2013; 13(2):123-30. PubMed ID: 23838141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]